Alzheimer’s Drug May Benefit Some Patients, New Data Shows

Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s

Amyloid Gains Converts in Debate Over Alzheimer’s Treatments

As FDA considers new Alzheimer’s drug, a case study details safety concerns

Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain

Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles

Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug

Brain Scan-Blood Test Panel Promises Improved Diagnosis of Brain Trauma Following Battlefield Blast Exposure

"It’s Time To Shift Tactics On Alzheimer’s Disease" - Claudia Wallis

"Alzheimer’s Meeting: Lifestyle Factors Are Best—and Only—Bet Now for Reducing Dementia Risk" - Karen Weintraub

Discovery’s Science Channel Partners With Mount Sinai Health System to Create Digital Series Featuring Innovations in Science and Medicine